Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 3/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 18/20 | 0.39 |
| ▸ | BLK | P51451 | 2/20 | 0.38 |
| ▸ | EGFR | P00533 | 1/20 | 0.38 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
| ▸ | FLT3 | P36888 | 1/20 | 0.38 |
| ▸ | TEC | P42680 | 1/20 | 0.38 |
| ▸ | TXK | P42681 | 1/20 | 0.38 |
| ▸ | BMX | P51813 | 1/20 | 0.38 |
| ▸ | ITK | Q08881 | 1/20 | 0.38 |
| ▸ | ERBB4 | Q15303 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30582631 | 0.91 | PDE2A (0.43) | RETKDRBTKEGFR | |
| SCHEMBL26107236 | 0.91 | BTK (0.43) | RETKDRBTKBLKEGFR | |
| SCHEMBL26105731 | 0.88 | BTK (0.50) | RETBTKBLKEGFRERBB2 | |
| SCHEMBL30582519 | 0.88 | BTK (0.50) | RETBTKBLKEGFRERBB2 | |
| SCHEMBL26105368 | 0.86 | SRC (0.40) | RETKDRBTKBLKEGFR | |
| SCHEMBL30582573 | 0.86 | SRC (0.40) | RETKDRBTKBLKEGFR | |
| SCHEMBL30582586 | 0.85 | SRC (0.41) | RETKDRBTKEGFR | |
| SCHEMBL26108691 | 0.85 | SRC (0.41) | RETKDRBTKEGFR | |
| SCHEMBL30582598 | 0.85 | SRC (0.40) | RETKDRBTKEGFR | |
| SCHEMBL26105312 | 0.85 | SRC (0.40) | RETKDRBTKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4499616-A1 | SPIROBICYCLIC COMPOUNDS | Acerand Therapeutics (Hong Kong) Limited (HK) | 2025-02-05 | — | — | EP | disclosed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023192502-A1 | SPIROBICYCLIC COMPOUNDS | ACERAND THERAPEUTICS (USA) LIMITED (US) | 2023-10-05 | — | — | WO | disclosed |